Literature DB >> 10450508

Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice.

A Suri1, J D Katz.   

Abstract

Insulin-dependent diabetes mellitus (IDDM) is an immunological disorder wherein autoimmune-mediated destruction of islet cells in the pancreas results in persistent hyperglycemia. The non-obese diabetic mouse model of IDDM has revealed the importance of multiple factors that impact upon the disease process; however, understanding of primary immune mechanisms leading to IDDM remains elusive. The emergence of transgenic mouse models for IDDM has made important contributions towards clarifying many of these factors, including the cell types, the various effector molecules and the genetic elements involved in the pathogenesis of IDDM. In this review, we will focus on the primary mechanism and mediators of islet beta-cell death, the impact of T-helper lymphocytes on disease progression and the potential role of major histocompatibility complex class II molecules in conferring susceptibility to IDDM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450508     DOI: 10.1111/j.1600-065x.1999.tb01306.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  10 in total

1.  Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes.

Authors:  Jonathan D Katz; Jennifer K Ondr; Robert J Opoka; Zacharias Garcia; Edith M Janssen
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

2.  In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model.

Authors:  Boris Calderon; Anish Suri; Emil R Unanue
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

3.  IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.

Authors:  Boris Calderon; Anish Suri; Xiaoou O Pan; Jason C Mills; Emil R Unanue
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

4.  Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes.

Authors:  A Crinò; M G Cavallo; S Corbi; C A Mesturino; F Ferrazzoli; G Coppolino; C Bizzarri; M Cervoni; L Monetini; P Pozzilli
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

5.  Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse.

Authors:  F D Shi; M Flodstrom; B Balasa; S H Kim; K Van Gunst; J L Strominger; S B Wilson; N Sarvetnick
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

6.  Characterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K/BxN mouse.

Authors:  Timothy P LaBranche; Cynthia L Hickman-Brecks; Debra M Meyer; Chad E Storer; Michael I Jesson; Kimberly M Shevlin; Fernando A Happa; Ruteja A Barve; David J Weiss; John C Minnerly; Jennifer L Racz; Paul M Allen
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

7.  Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cells.

Authors:  Shira Perez; Sigal Fishman; Amos Bordowitz; Alon Margalit; F Susan Wong; Gideon Gross
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

Review 8.  Type 1 diabetes: primary antigen/peptide/register/trimolecular complex.

Authors:  Tomasz Sosinowski; George S Eisenbarth
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

Review 9.  TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy.

Authors:  R S Bahn
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

10.  Oxidative stress and redox modulation potential in type 1 diabetes.

Authors:  Meghan M Delmastro; Jon D Piganelli
Journal:  Clin Dev Immunol       Date:  2011-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.